332 related articles for article (PubMed ID: 31647958)
1. Risk of death associated with kratom use compared to opioids.
Henningfield JE; Grundmann O; Babin JK; Fant RV; Wang DW; Cone EJ
Prev Med; 2019 Nov; 128():105851. PubMed ID: 31647958
[TBL] [Abstract][Full Text] [Related]
2. Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic.
Garcia-Romeu A; Cox DJ; Smith KE; Dunn KE; Griffiths RR
Drug Alcohol Depend; 2020 Mar; 208():107849. PubMed ID: 32029298
[TBL] [Abstract][Full Text] [Related]
3. The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and research.
Henningfield JE; Fant RV; Wang DW
Psychopharmacology (Berl); 2018 Feb; 235(2):573-589. PubMed ID: 29273821
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and circumstances of heroin and pharmaceutical opioid overdose deaths: Comparison across opioids.
Roxburgh A; Hall WD; Gisev N; Degenhardt L
Drug Alcohol Depend; 2019 Dec; 205():107533. PubMed ID: 31704378
[TBL] [Abstract][Full Text] [Related]
5. Kratom policy: The challenge of balancing therapeutic potential with public safety.
Prozialeck WC; Avery BA; Boyer EW; Grundmann O; Henningfield JE; Kruegel AC; McMahon LR; McCurdy CR; Swogger MT; Veltri CA; Singh D
Int J Drug Policy; 2019 Aug; 70():70-77. PubMed ID: 31103778
[TBL] [Abstract][Full Text] [Related]
6. Update on the Pharmacology and Legal Status of Kratom.
Prozialeck WC
J Am Osteopath Assoc; 2016 Dec; 116(12):802-809. PubMed ID: 27893147
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic and clinical assessment of kratom: An update.
White CM
Am J Health Syst Pharm; 2019 Nov; 76(23):1915-1925. PubMed ID: 31626272
[TBL] [Abstract][Full Text] [Related]
8. Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users.
Singh D; Yeou Chear NJ; Narayanan S; Leon F; Sharma A; McCurdy CR; Avery BA; Balasingam V
J Ethnopharmacol; 2020 Mar; 249():112462. PubMed ID: 31816368
[TBL] [Abstract][Full Text] [Related]
9. Self-reported prevalence and severity of opioid and kratom (Mitragyna speciosa korth.) side effects.
Saref A; Suraya S; Singh D; Grundmann O; Narayanan S; Swogger MT; Prozialeck WC; Boyer E; Chear NJY; Balasingam V
J Ethnopharmacol; 2019 Jun; 238():111876. PubMed ID: 31014959
[TBL] [Abstract][Full Text] [Related]
10. Kratom as a substitute for opioids: Results from an online survey.
Coe MA; Pillitteri JL; Sembower MA; Gerlach KK; Henningfield JE
Drug Alcohol Depend; 2019 Sep; 202():24-32. PubMed ID: 31284119
[TBL] [Abstract][Full Text] [Related]
11. The pharmacology and toxicology of kratom: from traditional herb to drug of abuse.
Warner ML; Kaufman NC; Grundmann O
Int J Legal Med; 2016 Jan; 130(1):127-38. PubMed ID: 26511390
[TBL] [Abstract][Full Text] [Related]
12. Drug-Induced Liver Injury Caused by Kratom Use as an Alternative Pain Treatment Amid an Ongoing Opioid Epidemic.
Osborne CS; Overstreet AN; Rockey DC; Schreiner AD
J Investig Med High Impact Case Rep; 2019; 7():2324709619826167. PubMed ID: 30791718
[TBL] [Abstract][Full Text] [Related]
13. Opioid-related deaths and previous care for drug use and pain relief in Sweden.
Fugelstad A; Thiblin I; Johansson LA; Ågren G; Sidorchuk A
Drug Alcohol Depend; 2019 Aug; 201():253-259. PubMed ID: 31260826
[TBL] [Abstract][Full Text] [Related]
14. Cohort Study of the Impact of High-Dose Opioid Analgesics on Overdose Mortality.
Dasgupta N; Funk MJ; Proescholdbell S; Hirsch A; Ribisl KM; Marshall S
Pain Med; 2016 Jan; 17(1):85-98. PubMed ID: 26333030
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic and clinical assessment of kratom.
White CM
Am J Health Syst Pharm; 2018 Mar; 75(5):261-267. PubMed ID: 29255059
[TBL] [Abstract][Full Text] [Related]
16. Nature's first "atypical opioids": Kratom and mitragynines.
Raffa RB; Pergolizzi JV; Taylor R; Ossipov MH;
J Clin Pharm Ther; 2018 Jun; 43(3):437-441. PubMed ID: 29520812
[TBL] [Abstract][Full Text] [Related]
17. Respiratory effects of oral mitragynine and oxycodone in a rodent model.
Henningfield JE; Rodricks JV; Magnuson AM; Huestis MA
Psychopharmacology (Berl); 2022 Dec; 239(12):3793-3804. PubMed ID: 36308562
[TBL] [Abstract][Full Text] [Related]
18. Kratom and Future Treatment for the Opioid Addiction and Chronic Pain: Periculo Beneficium?
Ismail I; Wahab S; Sidi H; Das S; Lin LJ; Razali R
Curr Drug Targets; 2019; 20(2):166-172. PubMed ID: 28443503
[TBL] [Abstract][Full Text] [Related]
19. Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report.
Torrico T; Patel K; Nikolov N; Salam MT; Padhy R; Weinstein D
Front Psychiatry; 2023; 14():1332999. PubMed ID: 38268564
[TBL] [Abstract][Full Text] [Related]
20. High-risk use by patients prescribed opioids for pain and its role in overdose deaths.
Gwira Baumblatt JA; Wiedeman C; Dunn JR; Schaffner W; Paulozzi LJ; Jones TF
JAMA Intern Med; 2014 May; 174(5):796-801. PubMed ID: 24589873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
